This inventor holds 1 USPTO granted patent and 2 published patent applications and 2 EPO patents. Top assignee: Poseida Therapeutics, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Joshua Rychak: Innovator in Genetic Modification
Introduction
Joshua Rychak is an inventor based in San Diego, CA. He has made significant contributions to the field of genetic modification, particularly through his work at Poseida Therapeutics, Inc. and the University of San Diego. Although he currently holds no granted patents, his research and innovative ideas are noteworthy.
Latest Patent Applications
Joshua Rychak has submitted several patent applications focused on compositions and methods for the delivery of nucleic acids. One of his applications details compositions and methods for the genetic modification of cells, including hepatocytes. The compositions can comprise lipid nanoparticles, which include at least one bioreducible ionizable cationic lipid, at least one structural lipid, at least one phospholipid, and at least one PEGylated lipid. Another application also addresses the genetic modification of cells, specifically resting T-cells and hepatocytes, utilizing lipid nanoparticles that consist of at least one multivalent cationic bolaform amphiphilic lipid, along with other essential components.
Conclusion
Joshua Rychak is an innovative inventor whose work in genetic modification holds promise for future advancements in the field. His latest patent applications reflect his commitment to developing effective methods for nucleic acid delivery.